ARCH VENTURE FUND V LP's Net Worth
$219 Million
Who is ARCH VENTURE FUND V LP?
ARCH VENTURE FUND V LP has an estimated net worth of $219 Million. This is based on reported shares across multiple companies, which include ALNYLAM PHARMACEUTICALS INC, IMPINJ INC, NeurogesX Inc, XCYTE THERAPIES INC, and Trubion Pharmaceuticals, Inc.
SEC CIK
ARCH VENTURE FUND V LP's CIK is 0001117120
Past Insider Trading and Trends
2016 was ARCH VENTURE FUND V LP's most active year for acquiring shares with 6 total transactions. ARCH VENTURE FUND V LP's most active month to acquire stocks was the month of June. 2007 was ARCH VENTURE FUND V LP's most active year for disposing of shares, totalling 11 transactions. ARCH VENTURE FUND V LP's most active month to dispose stocks was the month of April. 2011 saw ARCH VENTURE FUND V LP paying a total of $2,999,999.92 for 2,616,279 shares, this is the most they've acquired in one year. In 2016 ARCH VENTURE FUND V LP cashed out on 2,597,235 shares for a total of $671,356.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
IMPINJ INC (PI) Snapshot price: $165.4
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
|
∞
| 1.37M |
$10.73 | $204.50 | 1.37M |
Jul 26
| |||
Form 4
|
∞
| 1.36M |
$11.66 | $68.32 | 1.36M |
Jul 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NeurogesX Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +71.38% | 1.74M |
$1.65 | $2,877,906.90 | 4.19M |
Jul 21
| |||
Form 4
| +18.54% | 382.17K |
$6.18 | $2,361,810.60 | 2.44M |
Dec 24
| |||
Form 4
| +1,015.12% | 2.3M |
—
|
—
| 2.53M |
May 7
| |||
Form 4
|
∞
| 227K |
$11.00 | $2,497,000.00 | 227K |
May 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Trubion Pharmaceuticals, Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -2.36M |
—
|
—
|
0
|
Oct 28
| |||
Form 4
| +3,337.93% | 2.29M |
—
|
—
| 2.36M |
Oct 23
| |||
Form 4
| +187.86% | 44.64K |
$13.00 | $580,320.00 | 68.4K |
Oct 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ALNYLAM PHARMACEUTICALS INC (ALNY) Snapshot price: $246.78
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
XCYTE THERAPIES INC (CYCC) Snapshot price: $1.02
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 29
| |||
Form 4
|
∞
| 2.05M |
$8.00 | $1,500,000.00 | 2.05M |
Mar 19
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||